How much is the Atrial Fibrillation Market worth?
According to a new market research study of ‘Atrial Fibrillation Market to 2027 – Global Analysis and Forecasts by Treatment Type and End User.’ The global atrial fibrillation market is expected to reach US$ 18,085.96 Mn in 2027 from US$ 6,446.08 Mn in 2019. The market is estimated to grow with a CAGR of 14.0% from 2020-2027. The report provides trends prevailing in the global Atrial Fibrillation Market and the factors driving the market along with those that act as hindrances.
Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00003531/
Atrial fibrillation, is the most common type of heart disorder, where the heart beats too fast, too slow, or in an irregular way. The Centers for Disease Control and Prevention (CDC) estimated that between 2.7 million and 6.1 million people are suffering from AFib in the United States. In 2017, around 166,793 death certificates mention AFib and was the main cause death in 26,077 deaths. Every year over 454,000 hospitalizations were due to AFib in the United States and every year about 158,000 deaths are due to atrial fibrillation.
Furthermore, European Society of Cardiology reported that Atrial fibrillation is the most common arrhythmia and accounts for 0.28% to 2.6% of healthcare spending in European countries. It also mentioned that patients suffering from atrial fibrillation have a five times higher risk getting a stroke and 20% to 30% of total strokes in Europe are caused due to atrial fibrillation. As per the study conducted by the European Society of Cardiology in 2016, approximately 7.6 million people aged 65 or more in the EU had atrial fibrillation. The European Society of Cardiology estimated that the number is expected to increase by 89% in 2060 and approximately 14.4 million people will have atrial fibrillation. And the prevalence of 7.8% is expected to reach 9.5% in 2060.
Leading companies operating in the atrial fibrillation market are Boston Scientific Corporation, Medtronic, AtriCure, Inc, Biosense Webster, Inc., BOEHRINGER INGELHEIM GMBH, CardioFocus, Abbott, Sanofi, Biotronik, Inc., and Bristol-Myers Squibb Company among others.
Buy Now: https://www.theinsightpartners.com/buy/TIPRE00003531/
The report segments Global Atrial Fibrillation Market as follows:
Global Atrial Fibrillation Market – By Treatment Type
- Non – pharmacological
- MAZE Surgery
- Catheter Ablation
- Electric Cardioversion
- Anti-arrhythmic Drugs
- Anti-coagulant Drugs
Global Atrial fibrillation Market– By End User
- Ambulatory Surgical Centers,
- Cardiac Catheterization Laboratories
Our Most Selling Reports
DNA Next Generation Sequencing Market Growth 2022-2028
Biobased Propylene Market Growth 2022-2028
Compound Management Market Growth 2022-2028
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]